Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Abbey Dunn

Sleep Medicine Sylvania, OH Medical Doctor

NPI 1649536939 CMS profile 3220540

5700 Monroe St Unit 308, Sylvania, OH 43560

Open in the dashboard

General payments

$3,633

119 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Abbey Dunn of Sylvania, OH is reported in the CMS Open Payments database as having received $3,633 across 119 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 72nd percentile of Sleep Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $948 43
2024 General $948 50
2023 General $490 22
2022 General $1,247 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Abbey Dunn
  • Sleep Medicine median
  • Middle half of Sleep Medicine
  • National median

In program year 2025, general payments to Abbey Dunn were reported at $948. Among 263 Sleep Medicine profiles paid that year, the median was $337 and the middle half received between $114 and $1,241.

Show as a table
Year Abbey Dunn Sleep Medicine median Middle half National median
2019 $0 $206 $79–$855 $163
2020 $0 $170 $48–$1,437 $114
2021 $0 $178 $53–$1,297 $132
2022 $1,247 $313 $95–$1,332 $149
2023 $490 $307 $117–$1,081 $160
2024 $948 $308 $100–$1,432 $164
2025 $948 $337 $114–$1,241 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Inspire Medical Systems, Inc. $1,969 27 payments
  2. Jazz Pharmaceuticals Inc. $527 19 payments
  3. Axsome Therapeutics, Inc. $363 35 payments
  4. Harmony Biosciences LLC $295 11 payments
  5. Avadel CNS Pharmaceuticals, LLC $220 12 payments
  6. Idorsia Pharmaceuticals US Inc $69 5 payments
  7. Genzyme Corporation $55 3 payments
  8. Noctrix Health, Inc. $34 1 payment
  9. Inogen, Inc. $21 1 payment
  10. Janssen Pharmaceuticals, Inc $18 1 payment
  11. Other $64 4 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $2,851 115 payments
  2. Travel and Lodging $492 1 payment
  3. Education $290 3 payments
Products named General payments · program years 2022–2025
  1. Inspire Upper Airway Stimulation System $1,212 2 payments
  2. INSPIRE $757 25 payments
  3. Sunosi $363 35 payments
  4. XYWAV $337 17 payments
  5. LUMRYZ $220 12 payments
  6. XYREM $190 2 payments
  7. WAKIX Narcolepsy $99 5 payments
  8. QUVIVIQ $69 5 payments
  9. DUPIXENT $55 3 payments
  10. WAKIX Narcoplepsy $51 3 payments
  11. Other $181 9 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

114

Median for Neurology: 833

Drug cost

$879

Median for Neurology: $202,670

Branded share of claims

28.9%

Median for Neurology: 25.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Zolpidem Tartrate Er Zolpidem Tartrate Brand 14 $325
Gabapentin Generic 26 $191
Ropinirole Hcl Generic 23 $167
Pramipexole Dihydrochloride Pramipexole Di-Hcl Brand 19 $147
Zolpidem Tartrate Generic 32 $49

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,695 Part D prescribers listed as Neurology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 11 billing codes

Paid by Medicare

$38,197

Medicare's payments for the services billed

Medicare patients

328

Average age 70

Services billed

555

149 women, 179 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 55%
Ischemic heart disease 30%
Diabetes 28%
Atrial fibrillation 25%
Depression 24%
Chronic kidney disease 17%
Heart failure 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 6 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
LUMRYZ
  • Avadel CNS Pharmaceuticals, LLC $161
$161 — —
Sunosi
  • Axsome Therapeutics, Inc. $159
$159 — —
XYWAV
  • JAZZ PHARMACEUTICALS INC. $111
$111 — —
XYREM
  • JAZZ PHARMACEUTICALS INC. $100
$100 — —
QUVIVIQ
  • IDORSIA PHARMACEUTICALS US INC $56
$56 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 6 in the dashboard with a free account

Records

119 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sleep Medicine in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record